INSPIRA TECHNOLOGIES OXY B.H.N. LTD. Inspira Technologies Oxy B.H.N. Ltd. Share Price
Equities
IINN
IL0011715781
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.877 USD | -0.69% |
|
-1.22% | +77.07% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 14.17M 1.13B |
|---|---|---|---|---|---|
| Net income 2022 | -10M -796M | Net income 2023 | -11M -876M | EV / Sales 2022 | - |
| Net cash position 2022 | 12.45M 991M | Net cash position 2023 | 6.48M 516M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.36
x | P/E ratio 2023 |
-1.14
x | Employees | 40 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.53% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.59% | ||
| 1 week | -1.22% | ||
| Current month | +7.25% | ||
| 1 month | -1.22% | ||
| 3 months | +110.86% | ||
| 6 months | +52.59% | ||
| Current year | +77.07% |
1 week
1.84
1.97
1 month
1.642.36
Current year
0.762.36
1 year
0.762.49
3 years
0.769.59
5 years
0.769.59
10 years
0.769.59
| Managers | Title | Age | Since |
|---|---|---|---|
Joe Hayon
FOU | Founder | 50 | 30/06/17 |
| Founder | 47 | 30/06/17 | |
Yafit Tehila
DFI | Director of Finance/CFO | - | 31/01/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Benad Goldwasser
CHM | Chairman | 73 | 31/01/21 |
Limor Rozen
BRD | Director/Board Member | 50 | 15/07/21 |
| Founder | 47 | 30/06/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 1.877 | -0.69% | 26 829 |
| 26/04/24 | 1.89 | +0.53% | 74,794 |
| 25/04/24 | 1.88 | -2.59% | 114,703 |
| 24/04/24 | 1.93 | +3.76% | 134,854 |
| 23/04/24 | 1.86 | -2.11% | 48,038 |
Delayed Quote Nasdaq, April 29, 2024 at 07:20 pm
More quotes
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
Calendar
15/05/2024
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.89
USD
Average target price
13
USD
Spread / Average Target
+587.83%
| 1st Jan change | Capi. | |
|---|---|---|
| +77.07% | 32.68M | |
| -11.37% | 156M | |
| -14.72% | 81.85M | |
| +30.43% | 59.71M |
- Stock Market
- Equities
- IINN Stock
